PDBAX | PTTCX | PDBAX / PTTCX | |
Total Expense Ratio | 0.76 | 1.62 | 47% |
Annual Report Gross Expense Ratio | 0.77 | 1.62 | 48% |
Fund Existence | 31 years | 29 years | - |
Gain YTD | 6.174 | 6.226 | 99% |
Front Load | 3% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 51.2B | 44.8B | 114% |
Annual Yield % from dividends | 4.33 | 3.47 | 125% |
Returns for 1 year | 3.47 | 3.11 | 111% |
Returns for 3 years | 13.45 | 10.75 | 125% |
Returns for 5 years | -1.40 | -8.16 | 17% |
Returns for 10 years | 20.24 | 5.46 | 371% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IVLU | 35.43 | 0.37 | +1.06% |
iShares Edge MSCI Intl Value Factor ETF | |||
NUMG | 49.19 | 0.39 | +0.80% |
Nuveen ESG Mid-Cap Growth ETF | |||
EJAN | 32.95 | 0.14 | +0.41% |
Innovator Emerging Mkt Pwr Buff ETF™ Jan | |||
BOXA | 105.00 | 0.26 | +0.25% |
Alpha Architect Aggregate Bond ETF | |||
FTXH | 28.19 | -0.07 | -0.26% |
First Trust Nasdaq Pharmaceuticals ETF |